Susquehanna International Group
MRVI icon

Susquehanna International Group’s Maravai LifeSciences MRVI Stock Holding History

Susquehanna International Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Sell
128,800
-281,900
-69% -$956K ﹤0.01% 10429
2025
Q4 		$1.33M Buy
410,700
+67,000
+19% +$226K ﹤0.01% 6520
2025
Q3 		$986K Buy
343,700
+85,300
+33% +$218K ﹤0.01% 7400
2025
Q2 		$623K Buy
258,400
+49,200
+24% +$103K ﹤0.01% 8660
2025
Q1 		$462K Buy
209,200
+48,500
+30% +$192K ﹤0.01% 9065
2024
Q4 		$876K Buy
160,700
+13,000
+9% +$83.6K ﹤0.01% 7299
2024
Q3 		$1.23M Buy
147,700
+15,100
+11% +$131K ﹤0.01% 6341
2024
Q2 		$949K Sell
132,600
-96,300
-42% -$831K ﹤0.01% 6714
2024
Q1 		$1.98M Buy
228,900
+217,700
+1,944% +$1.47M ﹤0.01% 5361
2023
Q4 		$73.4K Sell
11,200
-93,900
-89% -$607K ﹤0.01% 11524
2023
Q3 		$1.05M Buy
105,100
+62,700
+148% +$688K ﹤0.01% 6525
2023
Q2 		$527K Buy
42,400
+25,000
+144% +$337K ﹤0.01% 8191
2023
Q1 		$244K Buy
+17,400
New +$250K ﹤0.01% 10177
2022
Q4 		– Sell
-23,100
Closed -$590K – 13217
2022
Q3 		$590K Sell
23,100
-20,500
-47% -$514K ﹤0.01% 8048
2022
Q2 		$1.24M Sell
43,600
-51,700
-54% -$1.64M ﹤0.01% 6000
2022
Q1 		$3.36M Sell
95,300
-44,900
-32% -$1.51M ﹤0.01% 4407
2021
Q4 		$5.87M Buy
140,200
+21,100
+18% +$855K ﹤0.01% 3486
2021
Q3 		$5.84M Buy
119,100
+72,700
+157% +$3.55M ﹤0.01% 3678
2021
Q2 		$1.94M Buy
46,400
+26,900
+138% +$1.04M ﹤0.01% 5992
2021
Q1 		$695K Sell
19,500
-112,000
-85% -$3.71M ﹤0.01% 8670
2020
Q4 		$3.69M Buy
+131,500
New +$3.66M ﹤0.01% 3952

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's MRVI Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 186,639 shares worth $528K. The stake represents ﹤0.01% of the portfolio and ranks #9527 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in MRVI as recently as Q3 2025.

Susquehanna International Group first reported a position in MRVI in Q1 2021 and has held it in 20 quarters since. The position peaked at $30.3M in Q2 2023. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Susquehanna International Group held 186,639 shares of Maravai LifeSciences worth $528K as of Q1 2026.
  • Maravai LifeSciences was a new Susquehanna International Group position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9527 holding.
  • Susquehanna International Group first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 20 quarters since.
  • Susquehanna International Group's Maravai LifeSciences position peaked at $30.3M in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.